Form 8-K · Current report
Automatic Data Processing 8-K, filed Oct 28, 2026
- Filed
- CIK
- 0000008670
- Accession no.
- 0000008670-26-000033
Summary
ADP reported first-quarter fiscal 2027 revenues up 6% to $5.5 billion, net earnings up 11% to $1.1 billion, and adjusted diluted EPS up 13% to $2.82, and raised its full-year revenue and adjusted diluted EPS growth guidance. CEO Maria Black said the results reflect business-model resilience and client demand, while CFO Peter Hadley said disciplined investment is supporting ADP's AI transformation.
Key points
- ADP revenues increased 6% year over year to $5.5 billion in the first quarter ended September 30, 2026, including 6% organic constant-currency growth.
- Net earnings increased 11% to $1.1 billion, adjusted EBIT increased 12% to $1.5 billion, and adjusted EBIT margin rose 130 basis points to 26.8%.
- Diluted EPS increased 14% to $2.83, and adjusted diluted EPS increased 13% to $2.82.
- ADP raised its full-year fiscal 2027 guidance for revenue growth to about 6% and adjusted diluted EPS growth to 10% to 12%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On October 28, 2026, the Registrant issued a press release announcing that the Registrant's financial results for the first quarter ended September 30, 2026 were available through an earnings release available on the Registrant's website. A copy of the Registrant's earnings release is attached hereto as Exhibit 99 and is hereby incorporated by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibit 99 Earnings Release dated October 28, 2026 issued by Automatic Data Processing, Inc. 104 Cover Page Interactive Data File, embedded in Inline XBRL. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.